樂觀
$7.05
情境價格
$0.574
+0.058 (+10.17%)收盤時
Callan JMB Inc. is a vertically integrated logistics and fulfillment company, which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. The Company provides comprehensive alternatives to all logistics solutions and services utilized for frozen shipping in the life sciences industry (personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). Its Ship2Q ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturers specifications equal to new off-the-shelf shipper systems.
Callan JMB Inc. is not a good buy right now due to significant financial losses and declining revenue. The current price is $0.57, with a staggering 1-year change of -85.83%, indicating a severe drop in value. Additionally, the company reported a net income loss of -$3,215,054 in Q1 2026, which raises concerns about its financial viability.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Callan JMB Acquires Reger Oil Energy Assets to Enhance Domestic Development

Callan JMB and ASU Partner to Establish Electrical Equipment Manufacturing Facility

Strategic Partnership Accelerates Pharmaceutical Onshoring

Callan JMB Expands Public Infrastructure Contract

CALLAN JMB INC AIMS TO SEEK FOREIGN-TRADE ZONE SUBZONE STATUS FOR ATLAS COMPLEX
Callan JMB Inc. is a vertically integrated logistics and fulfillment company, which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. The Company provides comprehensive alternatives to all logistics solutions and services utilized for frozen shipping in the life sciences industry (personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). Its Ship2Q ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturers specifications equal to new off-the-shelf shipper systems. It operates in the Industrials sector.
Callan JMB Inc. is not a good buy right now due to significant financial losses and declining revenue. The current price is $0.57, with a staggering 1-year change of -85.83%, indicating a severe drop in value. Additionally, the company reported a net income loss of -$3,215,054 in Q1 2026, which raises concerns about its financial viability.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。